Fingerprint
Dive into the research topics where Sun Young Oh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Trends in Incidence of Invasive Lobular Carcinoma of the Breast by Race: Patterns by Age, Cancer Stage, and Socioeconomic Factors in the United States, 1992-2019
Quinn, R. M., Bernal, A. M., Oh, S. Y. & Anampa, J. D., Jun 2025, In: Clinical breast cancer. 25, 4, p. e394-e402.e8Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Scopus citations -
Molecular profiling of serial liquid biopsy specimens utilizing cell free DNA (cfDNA) and circulating tumor cells (CTCs) in TBCRC041: A phase II study of alisertib in endocrine resistant metastatic breast cancer (MBC)
Giridhar, K., Suman, V. J., Tang, X., Ye, H., Campbell, J., Mayer, E. L., Karuturi, M. S., Morikawa, A., Kimmick, G. G., Isaacs, C., Oh, S. Y., Clark, A. S., Park, B. H., Bucheit, L. A., Tsai, J., Ingle, J. N., Goetz, M. P., D’assoro, A. B., Kalari, K. R. & Haddad, T. C., 2024, In: Journal of Clinical Oncology. 42, 16, 1037.Research output: Contribution to journal › Article › peer-review
-
Neoadjuvant T-DM1 for HER2-positive breast cancer used as a bridging strategy during COVID-19 pandemic: lessons learned—a case series
Choppa, A., Bhimani, F., Foley, A., Oh, S. Y., Makower, D., Feldman, S., Johnson, K., Bteich, F., Ramesh, K. H. & McEvoy, M. P., 2024, In: Gland Surgery. 13, 6, p. 1045-1053 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Evaluation of Alisertib Alone or Combined with Fulvestrant in Patients with Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial
Haddad, T. C., Suman, V. J., D'Assoro, A. B., Carter, J. M., Giridhar, K. V., McMenomy, B. P., Santo, K., Mayer, E. L., Karuturi, M. S., Morikawa, A., Marcom, P. K., Isaacs, C. J., Oh, S. Y., Clark, A. S., Mayer, I. A., Keyomarsi, K., Hobday, T. J., Peethambaram, P. P., O'Sullivan, C. C. & Leon-Ferre, R. A. & 3 others, , Jun 15 2023, In: JAMA Oncology. 9, 6, p. 815-824 10 p.Research output: Contribution to journal › Article › peer-review
Open Access44 Link opens in a new tab Scopus citations -
Randomized Phase II Trial of Endocrine Therapy with or Without Ribociclib after Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptora-Positive, Human Epidermal Growth Factor Receptor 2a-Negative Metastatic Breast Cancer: MAINTAIN Trial
Kalinsky, K., Accordino, M. K., Chiuzan, C., Mundi, P. S., Sakach, E., Sathe, C., Ahn, H., Trivedi, M. S., Novik, Y., Tiersten, A., Raptis, G., Baer, L. N., Oh, S. Y., Zelnak, A. B., Wisinski, K. B., Andreopoulou, E., Gradishar, W. J., Stringer-Reasor, E., Reid, S. A. & O'Dea, A. & 3 others, , Aug 20 2023, In: Journal of Clinical Oncology. 41, 24, p. 4004-4013 10 p.Research output: Contribution to journal › Article › peer-review
148 Link opens in a new tab Scopus citations